{"id":"https://openalex.org/W1986201857","doi":"https://doi.org/10.3109/03639045.2011.650645","title":"Formulation of ternary complexes of glyburide with hydroxypropyl-\u03b2-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds","display_name":"Formulation of ternary complexes of glyburide with hydroxypropyl-\u03b2-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds","publication_year":2012,"publication_date":"2012-01-28","ids":{"openalex":"https://openalex.org/W1986201857","doi":"https://doi.org/10.3109/03639045.2011.650645","mag":"1986201857","pmid":"https://pubmed.ncbi.nlm.nih.gov/22283512"},"language":"en","primary_location":{"id":"doi:10.3109/03639045.2011.650645","doi":"https://doi.org/10.3109/03639045.2011.650645","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639045.2011.650645","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035358791","display_name":"Sachin Kumar Singh","orcid":"https://orcid.org/0000-0003-3823-6572","observed_orcids":["https://orcid.org/0000-0003-3823-6572"]},"institutions":[{"id":"https://openalex.org/I65220239","display_name":"Karpagam Academy of Higher Education","ror":"https://ror.org/00ssvzv66","country_code":"IN","type":"education","lineage":["https://openalex.org/I65220239"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Sachin Kumar Singh","raw_affiliation_strings":["Department of Pharmacy, Karpagam University, Coimbatore, Tamilnadu, India. sachin_pharma06@yahoo.co.in","Department of Pharmacy, Karpagam University, Coimbatore, Tamilnadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Karpagam University, Coimbatore, Tamilnadu, India. sachin_pharma06@yahoo.co.in","institution_ids":["https://openalex.org/I65220239"]},{"raw_affiliation_string":"Department of Pharmacy, Karpagam University, Coimbatore, Tamilnadu, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103392610","display_name":"K. K. Srinivasan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164861460","display_name":"Manipal Academy of Higher Education","ror":"https://ror.org/02xzytt36","country_code":"IN","type":"education","lineage":["https://openalex.org/I164861460"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"K. K. Srinivasan","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Udupi, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Udupi, Karnataka, India","institution_ids":["https://openalex.org/I164861460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033693664","display_name":"Dhananjay S. Singare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dhananjay S. Singare","raw_affiliation_strings":["Custom Pharmaceutical Services-Formulations, Dr Reddys Laboratories Ltd., Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Custom Pharmaceutical Services-Formulations, Dr Reddys Laboratories Ltd., Hyderabad, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K. Gowthamarajan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Gowthamarajan","raw_affiliation_strings":["Department of Pharmaceutics, J.S.S college of Pharmacy, Rocklands, Ooty, Tamilnadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, J.S.S college of Pharmacy, Rocklands, Ooty, Tamilnadu, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113887968","display_name":"Dev Prakash","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dev Prakash","raw_affiliation_strings":["Department of Pharmacy, Karpagam University, Coimbatore, Tamilnadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Karpagam University, Coimbatore, Tamilnadu, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5035358791"],"corresponding_institution_ids":["https://openalex.org/I65220239"],"apc_list":null,"apc_paid":null,"fwci":1.7834,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.8236372,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"38","issue":"11","first_page":"1328","last_page":"1336"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":1.0},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.984000027179718},{"id":"https://openalex.org/keywords/ternary-complex","display_name":"ternary complex","score":0.8360000252723694},{"id":"https://openalex.org/keywords/solubilizers","display_name":"solubilizing agents","score":0.9150000214576721},{"id":"https://openalex.org/keywords/l-arginine","display_name":"L-arginine","score":0.8080000281333923},{"id":"https://openalex.org/keywords/dissolution-enhancement","display_name":"dissolution enhancement","score":0.7620000243186951},{"id":"https://openalex.org/keywords/stirring-speed","display_name":"stirring speed","score":0.765999972820282},{"id":"https://openalex.org/keywords/amorphous-solid-dispersions","display_name":"amorphous solid dispersions","score":0.8169999718666077},{"id":"https://openalex.org/keywords/molecular-encapsulation","display_name":"molecular encapsulation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/cyclodextrin-inclusion-complexes","display_name":"cyclodextrin inclusion complexes","score":0.6990000009536743},{"id":"https://openalex.org/keywords/sulfonylurea-antidiabetic-drugs","display_name":"sulfonylurea antidiabetic drugs","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C2780077769","wikidata":"https://www.wikidata.org/wiki/Q413433","display_name":"Polyvinylpyrrolidone","level":2,"score":0.779454231262207},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.6890261173248291},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6726372838020325},{"id":"https://openalex.org/C64452783","wikidata":"https://www.wikidata.org/wiki/Q1524945","display_name":"Ternary operation","level":2,"score":0.6704728007316589},{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.6364365220069885},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.6104146838188171},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5534082055091858},{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.4788498878479004},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.4630712568759918},{"id":"https://openalex.org/C122247533","wikidata":"https://www.wikidata.org/wiki/Q1056486","display_name":"Ternary numeral system","level":3,"score":0.45816096663475037},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.44090741872787476},{"id":"https://openalex.org/C86756495","wikidata":"https://www.wikidata.org/wiki/Q7702931","display_name":"Ternary complex","level":3,"score":0.4184921979904175},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.38389188051223755},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1810111105442047},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.1409246325492859},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002021","descriptor_name":"Buffers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002152","descriptor_name":"Calorimetry, Differential Scanning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010592","descriptor_name":"Pharmaceutic Aids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013314","descriptor_name":"Stress, Mechanical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014867","descriptor_name":"Water","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044367","descriptor_name":"Phase Transition","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/03639045.2011.650645","doi":"https://doi.org/10.3109/03639045.2011.650645","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639045.2011.650645","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},{"id":"pmid:22283512","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22283512","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development and industrial pharmacy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.504800021648407,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W151091843","https://openalex.org/W159649678","https://openalex.org/W183429264","https://openalex.org/W1498305210","https://openalex.org/W1968845856","https://openalex.org/W1975505859","https://openalex.org/W1981301581","https://openalex.org/W1981588418","https://openalex.org/W1983715551","https://openalex.org/W1988723809","https://openalex.org/W1990179098","https://openalex.org/W1996481160","https://openalex.org/W2000085374","https://openalex.org/W2000535771","https://openalex.org/W2011930026","https://openalex.org/W2022794794","https://openalex.org/W2022846728","https://openalex.org/W2024048542","https://openalex.org/W2029573539","https://openalex.org/W2031488480","https://openalex.org/W2046017608","https://openalex.org/W2052684858","https://openalex.org/W2056320380","https://openalex.org/W2064135629","https://openalex.org/W2071096394","https://openalex.org/W2072474446","https://openalex.org/W2075268393","https://openalex.org/W2085592625","https://openalex.org/W2096321754","https://openalex.org/W2097545597","https://openalex.org/W2144875070","https://openalex.org/W2283449839","https://openalex.org/W2323038396","https://openalex.org/W3021953557","https://openalex.org/W3114910014","https://openalex.org/W4240681501"],"related_works":["https://openalex.org/W2000535771","https://openalex.org/W1972891155","https://openalex.org/W1977664708","https://openalex.org/W1997849933","https://openalex.org/W2618258621","https://openalex.org/W2075399007","https://openalex.org/W4376612590","https://openalex.org/W117984517","https://openalex.org/W2062884058","https://openalex.org/W2155435315"],"abstract_inverted_index":{"Glyburide,":[0],"a":[1,34,72,121],"sulfonylurea":[2],"derivative,":[3],"widely":[4],"used":[5,28,54,87,104],"as":[6,46,48],"hypoglycaemic":[7],"agent.":[8],"In":[9],"the":[10,20,50,57,63,80,83,90,127,147,156,161,166,180,183],"present":[11],"study,":[12],"an":[13,170],"attempt":[14],"has":[15,125,145],"been":[16],"made":[17],"to":[18,32,41,70,78,105,133],"investigate":[19],"most":[21,148],"effective":[22],"third":[23],"component":[24],"which":[25],"can":[26],"be":[27],"with":[29,37,60,110,118,140],"hydroxylpropyl-\u03b2-cyclodextrin":[30],"(HP\u03b2Cd)":[31],"form":[33],"ternary":[35,91,107,115],"complex":[36,59,92],"glyburide":[38],"in":[39,76,120,163],"order":[40,77],"enhance":[42],"its":[43],"dissolution":[44,74,129,150],"rate,":[45],"well":[47],"reduce":[49],"amount":[51],"of":[52,65,82,123,165,172,179],"HP\u03b2Cd":[53,111],"for":[55,88],"formulating":[56,89],"binary":[58],"glyburide.":[61,113],"Moreover,":[62],"objective":[64],"this":[66],"study":[67],"was":[68,169],"also":[69],"develop":[71],"discriminatory":[73,149],"media":[75,139],"discriminate":[79],"effect":[81],"different":[84],"solubilizing":[85,135],"agents":[86],"system.":[93],"Sodium":[94],"lauryl":[95],"sulphate,":[96],"Poloxamer-188,":[97],"Polyvinylpyrrolidone":[98],"K-30,":[99],"lactose":[100],"and":[101,112,155],"L-arginine":[102],"were":[103],"formulate":[106],"system":[108,116],"along":[109],"The":[114,152],"formulated":[117],"glyburide:HP\u03b2Cd:L-arginine":[119],"proportion":[122],"1:1:0.5":[124],"shown":[126],"fastest":[128],"rate":[130],"when":[131],"compared":[132],"other":[134],"agents.":[136],"Unbuffered":[137],"aqueous":[138],"stirring":[141],"speed":[142],"50":[143],"rpm":[144],"produced":[146],"profiles.":[151],"DSC":[153],"thermograms":[154],"powder":[157],"X-ray":[158],"analysis":[159],"revealed":[160],"decrease":[162],"crystallinity":[164],"drug.":[167],"This":[168],"indication":[171],"amorphous":[173],"solid":[174],"dispersion":[175],"or":[176],"molecular":[177],"encapsulation":[178],"drug":[181],"into":[182],"cyclodextrin":[184],"cavity.":[185]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}